Imaging using radioisotopes is a rapidly developing field in diagnostic medicine. Positron emission tomography (PET) imaging uses shortlived radionuclides to measure biological processes at a molecular level in the living human body. Currently there are only a small number of PET radiopharmaceuticals available commercially and a major limiting factor is access to PET radionuclides. New methods for producing radionuclides that are both compact and inexpensive,should make them more widely available, and by extending their parameter range, stimulate new application areas.
The laser-plasma accelerator is a very recent ultracompact technology that is now attracting the attention of the scientific community. A multi-disciplinary collaboration between the University of Strathclyde, the University of
Glasgow and Greater Glasgow and Clyde NHS is looking at the potential utility of using gamma ray sources based on laser-plasma Wakefield accelerators (LPWA) for the production of medical isotopes. As well as existing
radionuclide targets, novel targets will be investigated, including radionuclides for use both in diagnostic imaging and in targeted radionuclide therapy.
Glasgow and Greater Glasgow and Clyde NHS is looking at the potential utility of using gamma ray sources based on laser-plasma Wakefield accelerators (LPWA) for the production of medical isotopes. As well as existing
radionuclide targets, novel targets will be investigated, including radionuclides for use both in diagnostic imaging and in targeted radionuclide therapy.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.